
Resolve Therapeutics, a 2-year-old Seattle biotechnology spin off from the University of Washington, has raised $5.8 million in new financing from New Science Ventures, WRF Capital and Easton Capital. The company will use the funds to continue to develop therapeutics for the treatment of Lupus, a life-threatening autoimmune disease that affects 1.5 million people in the United… Read More…



















![Seattle Sketch Comedy Month! [June] @ The Ballard Underground | Seattle | Washington | United States](http://2eq9hztv2wc1k6odx469m9znq0.wpengine.netdna-cdn.com/wp-content/uploads/215910-250-167x300.gif)









Most commented